Chargement en cours...
Fixed combination of repaglinide and metformin in the management of type 2 diabetes
Treatment to target fasting blood glucose (FBG), postprandial glucose (PPG) and HbA(1c) are essential in the management of type 2 diabetes to reduce the risk of vascular complications. Early combination therapy with oral agents is increasingly being seen as important to achieve this. Repaglinide, a...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3048008/ https://ncbi.nlm.nih.gov/pubmed/21437123 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|